Rick Sax

Rick Sax is an experienced senior pharma executive specializing in biotechnology start-ups and drug research and development. Formerly, they served as Senior VP at Quintiles Transnational and Clinical Vice-President at AstraZeneca, demonstrating expertise across various aspects of drug development, including translational and regenerative medicine. Currently, Rick holds advisory roles with Ascension Life Fund, Critical Path Institute, VeriSIM Life, PangaeaData.AI, and Radyus Research, while also contributing as an Advisory Board Member for Halloran Consulting Group. They earned an M.D. from Columbia University and completed a fellowship in Cardiovascular Medicine at the National Institutes of Health.